Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Tovorafenib for the Treatment of Newly Diagnosed or Recurrent Craniopharyngioma in Children and Young Adults

NCT05465174 is registered in ClinicalTrials.gov with Sabine Mueller, MD, PhD as lead sponsor.

NCT NCT05465174
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05465174 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Tovorafenib for the Treatment of Newly Diagnosed or Recurrent Craniopharyngioma in Children and Young Adults
Lead sponsor
Sabine Mueller, MD, PhD
Phase
Phase 2
Overall status
Recruiting
Start date
September 12, 2022
Completion date
March 1, 2028
Enrollment
57 (estimated)
Sites
20

Conditions

As the registry lists them; a condition with its own page is linked.

craniopharyngioma, craniopharyngioma, child, recurrent craniopharyngioma